Apotex Corp. is recalling 112,865 units of Paroxetine Hydrochloride Tablets (the generic version of the antidepressant Paxil) in 10 mg, 20 mg, 30 mg, and 40 mg strengths. The recall was issued because laboratory testing found levels of an impurity (Amadori Glucose adduct) that exceeded approved specifications. The affected products were distributed nationwide in various bottle sizes ranging from 30 to 1,000 tablets.
Taking medication that does not meet purity standards could expose patients to unintended degradation products, which may potentially impact the safety or effectiveness of the treatment.
You have 2 options:
Quantity affected: 34,392 units.
Quantity affected: 48,623 units.
Quantity affected: 25,776 units.
Quantity affected: 4,074 units.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.